{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:19:41Z","timestamp":1785831581752,"version":"3.56.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1097\/inf.0b013e318279e9a9","type":"journal-article","created":{"date-parts":[[2012,10,26]],"date-time":"2012-10-26T03:19:28Z","timestamp":1351221568000},"page":"383-388","source":"Crossref","is-referenced-by-count":10,"title":["Antibody Responses to Routine Pediatric Vaccines Administered With 13-valent Pneumococcal Conjugate Vaccine"],"prefix":"10.1097","volume":"32","author":[{"given":"Kristina A.","family":"Bryant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Gurtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Girgenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Reisinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Pride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio A.","family":"Emini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-28-20210202","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"R2-28-20210202","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1542\/peds.2003-0592-F","article-title":"Population-based impact of pneumococcal conjugate vaccine in young children.","volume":"114","author":"Poehling","year":"2004","journal-title":"Pediatrics"},{"key":"R3-28-20210202","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","article-title":"Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.","volume":"369","author":"Grijalva","year":"2007","journal-title":"Lancet"},{"key":"R4-28-20210202","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1128\/JCM.44.3.999-1017.2006","article-title":"Active Bacterial Core Surveillance Team. Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002.","volume":"44","author":"Beall","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R5-28-20210202","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.inf.0000202137.37642.ab","article-title":"Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.","volume":"25","author":"Byington","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R6-28-20210202","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/INF.0b013e31803df9ca","article-title":"Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.","volume":"26","author":"Pelton","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R9-28-20210202","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1542\/peds.2009-3027","article-title":"004 Study Group. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers.","volume":"126","author":"Yeh","year":"2010","journal-title":"Pediatrics"},{"key":"R10-28-20210202","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/CVI.00062-10","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers.","volume":"17","author":"Esposito","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R11-28-20210202","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1016\/j.vaccine.2011.06.026","article-title":"501 and 006 study groups. Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine.","volume":"29","author":"Gimenez-Sanchez","year":"2011","journal-title":"Vaccine"},{"key":"R12-28-20210202","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.inf.0000148923.46453.48","article-title":"Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate vaccine.","volume":"24","author":"Tichmann-Schumann","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R13-28-20210202","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1016\/j.vaccine.2006.03.032","article-title":"Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPVHib combination vaccine in healthy infants.","volume":"24","author":"Knuf","year":"2006","journal-title":"Vaccine"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-201304000-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T02:03:32Z","timestamp":1618020212000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201304000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318279e9a9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717962534.793465810","asserted-by":"object"}]},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}